UCLA Medical School

At the David Geffen School of Medicine at UCLA, Ground-Breaking Discoveries and Treatment are Just Steps Apart

From a top-notch education in a dynamic learning environment to paradigm-shifting research,
our world-changing approach will shape medicine for generations to come.

The Student Experience

We offer a world-class education in a dynamic learning environment with once-in-a-lifetime learning experiences

Explore Our Programs

Research

The David Geffen School of Medicine is one of the premier medical research centers in the nation

Learn About Our Breakthroughs

Our Learning Culture

We're a community defined by inclusive excellence and dedicated to changing the world through our work

See Our Values in Action

A Legacy Defined by Discovery

At the David Geffen School of Medicine and UCLA Health, research is the engine that drives progress. From identifying the first case of AIDS to pioneering targeted cancer therapies that have redefined treatment, our legacy is built on discovery. Breakthroughs like these don’t happen by chance. They happen because we invest in science, ask the hard questions and never stop searching for answers. We’re not only shaping the future of medicine, we’re changing lives around the world.

UCLA Hosts Rare Disease Registry

UCLA hosts the only Familial Mediterranean Fever program in the Western Hemisphere and maintains a registry/biobank of 700+ patients.

Learn About the Registry

AI-Powered Tool Helps Detect Rare Diseases

By definition, a rare disease affects fewer than 200,000 people. But more than 10,000 known rare diseases cumulatively affect 1 in 10 Americans.

Learn About the AI-powered Tool

Heart Research in Precision Health

1,400+ published research studies and clinical trials in heart failure, disease management, preventative cardiology, and outcomes research.

See the Research

The Growing Links Between Pesticides and Parkinson’s

Dr. Beate Ritz’s research in California’s Central Valley highlights the role of the environment in the neurodegenerative disorder.

Read About Dr. Ritz’s Research

25 Years After Approval, Herceptin Saves Lives

Herceptin, the first gene-based breast cancer drug developed by UCLA’s Dr. Dennis Slamon, changed the cancer treatment landscape.

Hear From Dr. Slamon

UCLA Health’s Shared Genomics Model

Genomic data drives innovations in human health. The Technology Center for Genetics and Bioinformatics provides the tools to advance biological research.

Learn More About the Model
First human bladder transplant, performed at UCLA Health

A UCLA Health team has performed the first human bladder transplant

UCLA Health Urology has long been at the frontier of urologic transplantation, with pioneering research in kidney transplantation and now, bladder transplantation.

Learn About This Breakthrough
Alzheimer's research microscopy

Crowdsourcing the Brain

One in three Americans is likely to be affected by a brain disorder in their lifetime. Many of these conditions, such as Alzheimer’s disease or severe developmental disorders, have no reliable treatment. Meta-atlases, a type of computational dataset, reveals new clues about development and disease.

Read About the UCLA Study
“It turns out SSRIs don’t just make our brains happier; they also make our T cells happier — even while they’re fighting tumors. These drugs have been widely and safely used to treat depression for decades, so repurposing them for cancer would be a lot easier than developing an entirely new therapy.”

– Lili Yang, PhD, Microbiology, Immunology & Molecular Genetics (MIMG)

Learn More About Dr. Yang’s Work

Latest News

Fred Ramsdell, PhD

UCLA alumnus Fred Ramsdell wins 2025 Nobel Prize in physiology or medicine

UCLA alumnus Fred Ramsdell wins 2025 Nobel Prize in physiology or medicine

Read the full article
2 min read
View All News Articles

Live Your Life of Impact Here

You'll find yourself in one of the most diverse cities in the world. Our community is made up of amazing, strong, and talented leaders who care deeply and work to impact our world for good.